Piramal Pharma Solutions Expands Aurora Operations with $1.75M Investment
Piramal Pharma Solutions , a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd., announced that its Aurora, Canada drug substance site has received a $1,753,620 investment from the Ontario government through the Life Sciences Scale-Up Fund (LSSUF), enabling PPS t…
